Pharmacoeconomic and Outcomes Research are steadily moving forward in Asia.
出版信息
Value Health Reg Issues. 2016 May;9:112. doi: 10.1016/j.vhri.2016.04.001. Epub 2016 May 3.
PMID:27881252
Abstract
摘要
相似文献
1
Pharmacoeconomic and Outcomes Research are steadily moving forward in Asia.
Value Health Reg Issues. 2016 May;9:112. doi: 10.1016/j.vhri.2016.04.001. Epub 2016 May 3.
2
Health-care systems and pharmacoeconomic research in Asia-Pacific region.
Value Health. 2008 Mar;11 Suppl 1:S137-55. doi: 10.1111/j.1524-4733.2008.00378.x.
3
Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.
Value Health. 2009 Nov-Dec;12 Suppl 3:S1-2. doi: 10.1111/j.1524-4733.2009.00618.x.
4
Guidelines for pharmacoeconomic studies. The ways forward.
Pharmacoeconomics. 1994 Dec;6(6):493-7. doi: 10.2165/00019053-199406060-00002.
5
What is next for pharmacoeconomics and outcomes research in Asia?
Value Health. 2004 Mar-Apr;7(2):118-32. doi: 10.1111/j.1524-4733.2004.72330.x.
6
Emerging health economics and outcomes research in the Asia-Pacific region.
Value Health. 2008 Mar;11 Suppl 1:S1-2. doi: 10.1111/j.1524-4733.2008.00360.x.
7
Bridging the gap in pharmacoeconomics and outcomes research between researchers, policymakers, and practitioners in the Asia-Pacific region.
Value Health. 2012 Jan-Feb;15(1 Suppl):S1-2. doi: 10.1016/j.jval.2011.11.021.
8
Obtaining pharmacoeconomic data in health care organizations.
Top Hosp Pharm Manage. 1994 Jan;13(4):23-30.
9
Can pharmacoeconomic guidelines be implemented successfully in Asia?
J Med Econ. 2008;11(2):341-3. doi: 10.3111/13696990802221171.
10
The use of claims databases in pharmacoeconomic studies.
Value Health. 2003 Mar-Apr;6(2):88-9. doi: 10.1046/j.1524-4733.2003.t01-1-00002.x.
Zotero 插件